Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Matthias Arnold

Showing results (91-100 of 114) with videos related to

Pageof 12
Sort By:
Science (New York, N.Y.)|October 14, 2021
Mapping the proteo-genomic convergence of human diseasesMaik Pietzner, Eleanor Wheeler, Julia Carrasco-Zanini, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|October 20, 2018
Altered bile acid profile in mild cognitive impairment and Alzheimer's disease: Relationship to neuroimaging and CSF biomarkersKwangsik Nho, Alexandra Kueider-Paisley, Siamak MahmoudianDehkordi, et al.
Communications Biology|October 8, 2022
Multi-Omic analyses characterize the ceramide/sphingomyelin pathway as a therapeutic target in Alzheimer's diseasePriyanka Baloni, Matthias Arnold, Luna Buitrago, et al.
Communications Medicine|January 8, 2025
Consuming a modified Mediterranean ketogenic diet reverses the peripheral lipid signature of Alzheimer's disease in humansBryan J Neth, Kevin Huynh, Corey Giles, et al.
Translational Psychiatry|March 3, 2021
Alterations in acylcarnitines, amines, and lipids inform about the mechanism of action of citalopram/escitalopram in major depressionSiamak MahmoudianDehkordi, Ahmed T Ahmed, Sudeepa Bhattacharyya, et al.
JAMA Psychiatry|April 19, 2023
Interplay of Metabolome and Gut Microbiome in Individuals With Major Depressive Disorder vs Control IndividualsNajaf Amin, Jun Liu, Bruno Bonnechere, et al.
Alzheimer'S & Dementia (New York, N. Y.)|March 12, 2024
New directions for Alzheimer's disease research from the Jackson Laboratory Center for Alzheimer's and Dementia Research 2022 workshopMaria A Telpoukhovskaia, Thomas J Murdy, Olivia J Marola, et al.
Nature Communications|February 28, 2017
Connecting genetic risk to disease end points through the human blood plasma proteomeKarsten Suhre, Matthias Arnold, Aditya Mukund Bhagwat, et al.
Journal of Affective Disorders|February 15, 2020
Acylcarnitine metabolomic profiles inform clinically-defined major depressive phenotypesAhmed T Ahmed, Siamak MahmoudianDehkordi, Sudeepa Bhattacharyya, et al.
Cell Reports|August 23, 2023
Cell-type-specific regulation of APOE and CLU levels in human neurons by the Alzheimer's disease risk gene SORL1Hyo Lee, Aimee J Aylward, Richard V Pearse, et al.
Pageof 12

Showing results (91-100 of 114) with videos related to

Sort By:
Pageof 12
Science (New York, N.Y.)|October 14, 2021
Mapping the proteo-genomic convergence of human diseasesMaik Pietzner, Eleanor Wheeler, Julia Carrasco-Zanini, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|October 20, 2018
Altered bile acid profile in mild cognitive impairment and Alzheimer's disease: Relationship to neuroimaging and CSF biomarkersKwangsik Nho, Alexandra Kueider-Paisley, Siamak MahmoudianDehkordi, et al.
Communications Biology|October 8, 2022
Multi-Omic analyses characterize the ceramide/sphingomyelin pathway as a therapeutic target in Alzheimer's diseasePriyanka Baloni, Matthias Arnold, Luna Buitrago, et al.
Communications Medicine|January 8, 2025
Consuming a modified Mediterranean ketogenic diet reverses the peripheral lipid signature of Alzheimer's disease in humansBryan J Neth, Kevin Huynh, Corey Giles, et al.
Translational Psychiatry|March 3, 2021
Alterations in acylcarnitines, amines, and lipids inform about the mechanism of action of citalopram/escitalopram in major depressionSiamak MahmoudianDehkordi, Ahmed T Ahmed, Sudeepa Bhattacharyya, et al.
JAMA Psychiatry|April 19, 2023
Interplay of Metabolome and Gut Microbiome in Individuals With Major Depressive Disorder vs Control IndividualsNajaf Amin, Jun Liu, Bruno Bonnechere, et al.
Alzheimer'S & Dementia (New York, N. Y.)|March 12, 2024
New directions for Alzheimer's disease research from the Jackson Laboratory Center for Alzheimer's and Dementia Research 2022 workshopMaria A Telpoukhovskaia, Thomas J Murdy, Olivia J Marola, et al.
Nature Communications|February 28, 2017
Connecting genetic risk to disease end points through the human blood plasma proteomeKarsten Suhre, Matthias Arnold, Aditya Mukund Bhagwat, et al.
Journal of Affective Disorders|February 15, 2020
Acylcarnitine metabolomic profiles inform clinically-defined major depressive phenotypesAhmed T Ahmed, Siamak MahmoudianDehkordi, Sudeepa Bhattacharyya, et al.
Cell Reports|August 23, 2023
Cell-type-specific regulation of APOE and CLU levels in human neurons by the Alzheimer's disease risk gene SORL1Hyo Lee, Aimee J Aylward, Richard V Pearse, et al.
Pageof 12